The FDA has updated information on the recalls of Philips Respironics OLA+ ventilators, now reporting seven deaths and 911 reports, including malfunctions, injuries, and deaths. The recall was prompted by ventilator inoperative alarms failing, leading to potential adverse effects such as respiratory failure and death. The FDA urges clinicians to follow the recommendations in the recall notice and consider discontinuing use of affected devices if the risks outweigh benefits for patients. Further research is needed to improve the safety of these devices with better-designed backup systems. Venkateshiah from Emory University advises caution in using these devices for unstable patients.
Source link